Small Molecule Discovery
Hyper Screeing
Rapidly screen massive compound libraries with HyperScreening to uncover high-potential hits.
Automated Molecular Design
Hyper Screening is a virtual screening tool designed to identify active compounds. Using Hyper Screening, you can search a library of 600,000 to 1,000,000 molecules provided by Hyper Lab within 24 hours to select molecular structures likely to bind to the target protein.
Hierarchy-Based Design Management
Hyper Screening employs HITS’ unique physics-deep learning fusion algorithm, which uses generalized AI technology with high accuracy for untrained proteins.
This significantly improves the success rate and cost efficiency of drug development.
Provide a selection of 500 molecules
Provide a selection of 500 molecules
We offer a list of the top 500 molecules based on binding score criteria for the target, along with their binding score and structures.
Results can be seen within 24-48 hours for 1 million molecules.
We offer a list of the top 500 molecules based on binding score criteria for the target, along with their binding score and structures.
Results can be seen within 24-48 hours for 1 million molecules.
Easily use the pre-processed library
No need for cumbersome meetings with external vendors
A process that usually takes several months can be completed in just a few days
Ready to revolutionize
Your drug discovery process?
Sign up with your email and start using HyperLab right now
—
AI drug discovery Platform
HITS Inc.
CEO : Woo Youn Kim
Address : 8F, 28, Teheran-ro 4-gil, Gangnam-gu, Seoul, Republic of Korea
© HITS Inc. All rights reserved.
Ready to revolutionize
Your drug discovery process?
Sign up with your email and start using HyperLab right now
HITS Inc.
CEO : Woo Youn Kim
Address : 8F, 28, Teheran-ro 4-gil, Gangnam-gu,
Seoul, Republic of Korea
© HITS Inc. All rights reserved.
Ready to revolutionize
Your drug discovery process?
Sign up with your email and start using HyperLab right now
—
AI drug discovery Platform
Small Molecule Discovery
Publications
HITS Inc.
CEO : Woo Youn Kim
Address : 8F, 28, Teheran-ro 4-gil, Gangnam-gu, Seoul, Republic of Korea
© HITS Inc. All rights reserved.
Small Molecule Discovery
Rapidly screen massive compound libraries with Hyper Screening to uncover high-potential hits.
Hyper Screeing
Automated Molecular Design
Hyper Screening is a virtual screening tool designed to identify active compounds. Using Hyper Screening, you can search a library of 600,000 to 1,000,000 molecules provided by Hyper Lab within 24 hours to select molecular structures likely to bind to the target protein.
Hierarchy-Based Design Management
Hyper Screening employs HITS’ unique physics-deep learning fusion algorithm, which uses generalized AI technology with high accuracy for untrained proteins. This significantly improves the success rate and cost efficiency of drug development.
Small Molecule Discovery
Hyper Screening
Rapidly screen massive compound libraries with Hyper Screening to uncover high-potential hits.